Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -475 | -257 | -210 | N/A | -10,354 |
| Accounts payable and accrued liabilities | N/A | N/A | -18 | N/A | 11 |
| Other Working Capital | -585 | -609 | -15 | N/A | 6,193 |
| Other Operating Activity | 6 | 3 | 18 | 0 | 886 |
| Operating Cash Flow | $-1,054 | $-862 | $-225 | $N/A | $-3,263 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2,050 |
| Debt Issued | 953 | 950 | N/A | N/A | N/A |
| Other Financing Activity | 90 | 0 | 70 | 0 | 303 |
| Financing Cash Flow | $1,043 | $950 | $70 | $N/A | $2,353 |
| Beginning Cash Position | 19 | 19 | 174 | N/A | 995 |
| End Cash Position | 8 | 106 | 19 | N/A | 85 |
| Net Cash Flow | $-11 | $88 | $-155 | $N/A | $-910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,054 | -862 | -225 | N/A | -3,263 |
| Free Cash Flow | -1,054 | -862 | -225 | 0 | -3,263 |